These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 29683392
1. Synthetic polymannose as a drug carrier: synthesis, toxicity and anti-fungal activity of polymannose-amphotericin B conjugates. Francis AP, Gurudevan S, Jayakrishnan A. J Biomater Sci Polym Ed; 2018 Sep; 29(13):1529-1548. PubMed ID: 29683392 [Abstract] [Full Text] [Related]
2. Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents. Ravichandran V, Kesavan V, Cojean S, Loiseau PM, Jayakrishnan A. Curr Drug Deliv; 2018 Sep; 15(7):1028-1037. PubMed ID: 29732967 [Abstract] [Full Text] [Related]
3. Synthesis and evaluation of anti-fungal activities of sodium alginate-amphotericin B conjugates. Ravichandran V, Jayakrishnan A. Int J Biol Macromol; 2018 Mar; 108():1101-1109. PubMed ID: 29126939 [Abstract] [Full Text] [Related]
4. Amphotericin B-albumin conjugates: Synthesis, toxicity and anti-fungal activity. Gurudevan S, Francis AP, Jayakrishnan A. Eur J Pharm Sci; 2018 Mar 30; 115():167-174. PubMed ID: 29325755 [Abstract] [Full Text] [Related]
5. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation. Gangadhar KN, Adhikari K, Srichana T. Int J Pharm; 2014 Aug 25; 471(1-2):430-8. PubMed ID: 24907597 [Abstract] [Full Text] [Related]
6. Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi. Nishi KK, Antony M, Mohanan PV, Anilkumar TV, Loiseau PM, Jayakrishnan A. Pharm Res; 2007 May 25; 24(5):971-80. PubMed ID: 17372682 [Abstract] [Full Text] [Related]
7. Synthetic Polysaccharides as Drug Carriers: Synthesis of Polyglucose-Amphotericin B Conjugates and In Vitro Evaluation of Their Anti-Fungal and Anti-Leishmanial Activities. Ravichandran V, Kothandaraman GP, Bories C, Loiseau PM, Jayakrishnan A. J Nanosci Nanotechnol; 2018 Apr 01; 18(4):2405-2414. PubMed ID: 29442909 [Abstract] [Full Text] [Related]
8. A novel injectable water-soluble amphotericin B-arabinogalactan conjugate. Falk R, Domb AJ, Polacheck I. Antimicrob Agents Chemother; 1999 Aug 01; 43(8):1975-81. PubMed ID: 10428922 [Abstract] [Full Text] [Related]
10. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles. Moraes Moreira Carraro TC, Altmeyer C, Maissar Khalil N, Mara Mainardes R. J Mycol Med; 2017 Dec 15; 27(4):519-529. PubMed ID: 28797532 [Abstract] [Full Text] [Related]
11. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates. Thanathanee O, Miller D, Ringel DM, Schaffner CP, Alfonso EC, O'Brien TP. J Ocul Pharmacol Ther; 2012 Dec 15; 28(6):589-92. PubMed ID: 22788845 [Abstract] [Full Text] [Related]
12. Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier. Usman F, Khalil R, Ul-Haq Z, Nakpheng T, Srichana T. AAPS PharmSciTech; 2018 Jul 15; 19(5):2077-2086. PubMed ID: 29691753 [Abstract] [Full Text] [Related]
13. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects. Charvalos E, Tzatzarakis MN, Van Bambeke F, Tulkens PM, Tsatsakis AM, Tzanakakis GN, Mingeot-Leclercq MP. J Antimicrob Chemother; 2006 Feb 15; 57(2):236-44. PubMed ID: 16361329 [Abstract] [Full Text] [Related]
14. Conjugating doxorubicin to polymannose: a new strategy for target specific delivery to lung cancer cells. Francis AP, Jayakrishnan A. J Biomater Sci Polym Ed; 2019 Nov 15; 30(16):1471-1488. PubMed ID: 31322972 [Abstract] [Full Text] [Related]
15. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B. Song Z, Wen Y, Deng P, Teng F, Zhou F, Xu H, Feng S, Zhu L, Feng R. Carbohydr Polym; 2019 Feb 01; 205():571-580. PubMed ID: 30446143 [Abstract] [Full Text] [Related]
16. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B. Ludwig DB, de Camargo LEA, Khalil NM, Auler ME, Mainardes RM. Mycopathologia; 2018 Aug 01; 183(4):659-668. PubMed ID: 29497926 [Abstract] [Full Text] [Related]
17. Amphotericin B aggregation inhibition with novel nanoparticles prepared with poly(epsilon-caprolactone)/poly(n,n-dimethylamino-2-ethyl methacrylate) diblock copolymer. Shim YH, Kim YC, Lee HJ, Bougard F, Dubois P, Choi KC, Chung CW, Kang DH, Jeong YI. J Microbiol Biotechnol; 2011 Jan 01; 21(1):28-36. PubMed ID: 21301189 [Abstract] [Full Text] [Related]
18. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo. Tang X, Zhu H, Sun L, Hou W, Cai S, Zhang R, Liu F. Int J Nanomedicine; 2014 Jan 01; 9():5403-13. PubMed ID: 25473279 [Abstract] [Full Text] [Related]
19. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans. Zia Q, Khan AA, Swaleha Z, Owais M. Int J Nanomedicine; 2015 Jan 01; 10():1769-90. PubMed ID: 25784804 [Abstract] [Full Text] [Related]
20. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment. Nimtrakul P, Tiyaboonchai W, Lamlertthon S. Curr Drug Deliv; 2019 Jan 01; 16(7):645-653. PubMed ID: 31362675 [Abstract] [Full Text] [Related] Page: [Next] [New Search]